A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Concerning symptoms accompanying hunger : Seek prompt medical attention if persistent hunger occurs alongside symptoms such as excessive thirst, frequent urination, unexplained weight loss despite increased appetite, or signs of hypoglycemia (shakiness, sweating, confusion)
For gastrointestinal conditions specifically, some clinicians use oral capsules, since the peptide acts directly on the gut lining
Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) that stimulates the pituitary gland to secrete growth hormone